Debloat & Detox Effectiveness Research Abstract
Effectiveness of Debloat & Detox for Gut Health: User-Reported Outcomes from a Cross-Sectional Survey
October 2022
Key Findings
- 80.7% of definitively rated users reported a combined positive effectiveness rating for Debloat & Detox (n=285, excluding ‘too early to tell’).
- 37.5% rated Debloat & Detox as extremely or very effective - the highest response categories.
- 53.5% of users experiencing improvements did so within two weeks; 73.5% within three weeks.
- Bloating was the dominant area of improvement (68.8%), followed by excessive wind or gas (28.7%) - reflecting the product’s targeted formulation.
- 61.6% of users gave a likelihood-to-recommend score of 7–10 out of 10.
Background
Debloat & Detox® is a nutritional supplement in the DRV+ (Formerly DR.VEGAN®) range, targeted specifically at bloating and associated digestive discomfort. Bloating is the most prevalent gut health symptom and one of the most commonly cited motivations for investing in gut health in surveys conducted by DRV+ (77.3% of respondents), so a product focused on this symptom addresses a primary unmet need. This abstract reports individual-level user-reported outcomes for Debloat & Detox from a wider cross-sectional survey, including effectiveness, time to benefit, and benefit profile. The survey was conducted by DRV+, October 2022.
Methods
Of 811 survey respondents, 738 answered whether they had tried Debloat & Detox. Those who had (n=335) were asked: their overall effectiveness rating (six-point scale); time to benefit; and which specific areas had improved. A likelihood-to-recommend score (1–10) was also collected. A secondary analysis excluded respondents who answered ‘too early to tell’ (n=49), leaving a rated cohort of 285. All analyses are based on individual-level data.
Results
Uptake
Of 738 respondents who answered the Debloat & Detox question, 335 (45.4%) had tried the product.
Overall effectiveness
Across all 334 rated users, 11.4% (n=38) rated Debloat & Detox as extremely effective, 20.7% (n=69) as very effective, and 36.8% (n=123) as somewhat effective. A total of 9.0% (n=30) rated it not so effective, 7.5% (n=25) not at all effective, and 14.7% (n=49) too early to tell. Among the 285 definitively rated users (excluding ‘too early to tell’), the combined positive response rate was 80.7%, with 37.5% rating Debloat & Detox as extremely or very effective. The negative response rate among rated users was 19.3%. See Figure 1 for the full effectiveness distribution.
| Effectiveness rating | n | % excl. 'too early' |
|---|---|---|
| Extremely effective | 38 | 13.3% |
| Very effective | 69 | 24.2% |
| Somewhat effective | 123 | 43.2% |
| Combined positive (ext+very+somewhat) | 230 | 80.7% |
| Not so effective | 30 | 10.5% |
| Not at all effective | 25 | 8.8% |
| Too early to tell | 49 | — |
Comparison with Gut Works®
Gut Works® achieved a combined positive rate of 83.0% among rated users, compared with 80.7% for Debloat & Detox. These differences likely reflect the broader multi-symptom formulation of Gut Works® relative to the more targeted bloating and digestive profile of Debloat & Detox.
Time to benefit
Of 295 users who reported improvements, 22.0% (n=65) noticed improvement within the first week, and 31.5% (n=93) within 1–2 weeks. Cumulatively, 53.5% of users experiencing improvements did so within two weeks, and 73.5% within three weeks.
| Area of improvement | n | % of users (n=321) |
|---|---|---|
| Bloating | 221 | 68.8% |
| Excessive wind or gas | 92 | 28.7% |
| Constipation | 63 | 19.6% |
| Diarrhoea | 31 | 9.7% |
| Stomach cramps | 29 | 9.0% |
| Reflux | 25 | 7.8% |
Likelihood to recommend
Of 318 respondents who provided a recommendation score, the mean was 7 out of 10 (median 8). A total of 34.3% (n=109) gave a score of 9 or 10, and a further 27.4% (n=87) scored 7 or 8, giving a combined 7–10 score from 61.6% of users.
Conclusions
Based on user-reported outcomes, individual-level analysis of this survey demonstrates that Debloat & Detox achieves a combined positive response rate of 80.7% among definitively rated users, with over half experiencing improvements within two weeks. Its benefit profile is tightly focused on bloating and wind, the two most prevalent gut symptoms in this population, making it a well-targeted option for individuals whose principal concerns are in these categories. Debloat & Detox addresses real, high-burden needs within this population.
Keywords: Debloat & Detox, bloating, gut health, wind and gas, constipation, user-reported outcomes, digestive supplement, nutritional supplement, IBS, women’s health
Survey date: 2024 | Debloat & Detox users: N = 335 | Rated users (excl. 'too early'): N = 285
Media enquiries: Please contact drv@thephagroup.com | drv.co